2 results
Approved WMOCompleted
To evaluate safety of 3-months versus standard 12-months of DAPT
Approved WMORecruiting
The purpose of this study is to evaluate the safety, pharmacokinetics, pharmacodynamics and activity of ACP-196 in treating subjects with Waldenström disease.